皮科纳病毒之间的多价值相互作用 3C(D) 主蛋白酶和RNA寡核酸诱导液-液相分离
Somnath Mondal1, Saumyak Mukherjee2, Kevin E W Namitz1
1Department of Chemistry, The Pennsylvania State University, University Park, PA 16801, USA.
Viruses
|November 27, 2025
概括
皮科纳病毒3C蛋白与RNA结合,其序列依赖性很小. 这种相互作用可以触发液-液相分离 (LLPS),这种过程可能会影响病毒复制和宿主细胞的反应,如亡.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 皮科纳病毒3CD蛋白对于病毒复制至关重要,作为蛋白酶和RNA聚合酶的前体.
- 3C蛋白酶域与病毒RNA元素 (CREs) 相互作用,以调节病毒过程.
- 了解3C-RNA相互作用对于破译病毒复制机制至关重要.
研究的目的:
- 研究由皮科纳病毒3C蛋白结合RNA的分子基础.
- 确定3C-RNA相互作用的序列和结构依赖性.
- 探索3C-RNA相互作用诱导液-液相分离 (LLPS) 的潜力.
主要方法:
- 使用了生物物理技术 (例如,光谱,结合试验).
- 使用计算方法分析蛋白质-RNA相互作用.
- 通过使用各种寡核酸序列和结构来评估RNA结合的亲缘关系和特异性.
主要成果:
- 3C蛋白与广泛的RNA寡核酸结合.
- 通过3C的RNA结合显示了短RNA的最小序列和结构依赖.
- 发现3C-RNA和3CD-RNA相互作用都会诱导液体-液体相分离 (LLPS).
结论:
- 皮科纳病毒3C蛋白具有非特异性的RNA结合能力.
- 3C-RNA相互作用可以驱动LLPS,这表明一种新的调节机制.
- 这些发现可能会提供有关病毒病原,亡和压力颗粒动态的见解.
相关概念视频
Viruses with RNA Genomes
765
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
765
RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K


